Roswell Park Comprehensive Cancer Center

Poor physical function correlated with outcomes among patients with non-Hodgkin lymphoma who underwent chimeric antigen receptor T-cell therapy, according to results of a retrospective cohort study.

Single-fraction stereotactic body radiation therapy may be an effective treatment for individuals with central lung cancer, according to prospective study results presented at American Society for Radiation Oncology Annual Meeting.

Inherited variants in DNA repair genes such as BRCA1 and BRCA2 may increase risk for multiple myeloma, according to results of a retrospective study.

Disparities in hematopoietic stem cell transplantation utilization for blood cancers have narrowed over time but still persist, according to study results.

Although progress has been made, lack of diversity continues to be problematic in trials of immune checkpoint inhibitors, according to study results.

Six months after the ransomware attack on Change Healthcare, the far-reaching impacts on medical practices, providers and patients continue to be felt.

Patients with breast cancer who reported high burdens of pain and stress had poorer outcomes than those with lower pain or stress levels, according to research presented at ASCO Annual Meeting.

CHICAGO — In partnership with COSMO, Healio awarded the Social Media Influencer award for 2024 to the Oncology Brothers.

Two blood biomarkers — pre-lymphodepletion C-reactive protein and ferritin — may help predict which patients with lymphoma are at risk for poor outcomes after chimeric antigen receptor T-cell therapy.

The Lymphoma Research Foundation formed a multidisciplinary consortium dedicated to advancing and harmonizing treatment for adolescents and young adults with lymphoma.